These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 25459105)

  • 21. Motor phenotypes, medication and mood: further associations with impulsive behaviours in Parkinson's disease.
    Hurt CS; Alkufri F; Brown RG; Burn DJ; Hindle JV; Landau S; Wilson KC; Samuel M;
    J Parkinsons Dis; 2014; 4(2):245-54. PubMed ID: 24366927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of impulse control disorders in Parkinson's disease.
    Mamikonyan E; Siderowf AD; Duda JE; Potenza MN; Horn S; Stern MB; Weintraub D
    Mov Disord; 2008 Jan; 23(1):75-80. PubMed ID: 17960796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levodopa medication improves incidental sequence learning in Parkinson's disease.
    Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
    Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortical thickness changes in patients with Parkinson's disease and impulse control disorders.
    Tessitore A; Santangelo G; De Micco R; Vitale C; Giordano A; Raimo S; Corbo D; Amboni M; Barone P; Tedeschi G
    Parkinsonism Relat Disord; 2016 Mar; 24():119-25. PubMed ID: 26810913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impulsive choice and response in dopamine agonist-related impulse control behaviors.
    Voon V; Reynolds B; Brezing C; Gallea C; Skaljic M; Ekanayake V; Fernandez H; Potenza MN; Dolan RJ; Hallett M
    Psychopharmacology (Berl); 2010 Jan; 207(4):645-59. PubMed ID: 19838863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study.
    Wirth T; Goetsch T; Corvol JC; Roze E; Mariani LL; Vidailhet M; Grabli D; Mallet L; Pelissolo A; Rascol O; Brefel-Courbon C; Ory-Magne F; Arbus C; Bekadar S; Krystkowiak P; Marques A; Llorca M; Krack P; Castrioto A; Fraix V; Maltete D; Defebvre L; Kreisler A; Houeto JL; Tranchant C; Meyer N; Anheim M
    J Neurol; 2024 May; 271(5):2412-2422. PubMed ID: 38214756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
    Wolters ECh; van der Werf YD; van den Heuvel OA
    J Neurol; 2008 Sep; 255 Suppl 5():48-56. PubMed ID: 18787882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impulsive-compulsive behaviors in parkin-associated Parkinson disease.
    Morgante F; Fasano A; Ginevrino M; Petrucci S; Ricciardi L; Bove F; Criscuolo C; Moccia M; De Rosa A; Sorbera C; Bentivoglio AR; Barone P; De Michele G; Pellecchia MT; Valente EM
    Neurology; 2016 Oct; 87(14):1436-1441. PubMed ID: 27590295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation.
    Simoni S; Paoletti FP; Eusebi P; Cappelletti G; Filidei M; Brahimi E; Nigro P; Santangelo V; Parnetti L; Calabresi P; Tambasco N
    J Parkinsons Dis; 2020; 10(3):927-934. PubMed ID: 32280105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of behavioural addiction in Parkinson's disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case-control study.
    Leplow B; Renftle D; Thomas M; Michaelis K; Solbrig S; Maetzler W; Berg D; Liepelt-Scarfone I
    J Neural Transm (Vienna); 2023 Feb; 130(2):125-133. PubMed ID: 36662280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.
    Smith KM; Xie SX; Weintraub D
    J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):864-70. PubMed ID: 26534930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risky business of dopamine agonists in Parkinson disease and impulse control disorders.
    Claassen DO; van den Wildenberg WPM; Ridderinkhof KR; Jessup CK; Harrison MB; Wooten GF; Wylie SA
    Behav Neurosci; 2011 Aug; 125(4):492-500. PubMed ID: 21604834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypersexuality and other impulse control disorders in Parkinson's disease].
    Nelis EA; Berendse HW; van den Heuvel OA
    Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease.
    Catalán MJ; de Pablo-Fernández E; Villanueva C; Fernández-Diez S; Lapeña-Montero T; García-Ramos R; López-Valdés E
    Mov Disord; 2013 Dec; 28(14):2007-10. PubMed ID: 24123193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease.
    Kim J; Kim M; Kwon DY; Seo WK; Kim JH; Baik JS; Koh SB
    J Neurol; 2013 Feb; 260(2):429-37. PubMed ID: 22893307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease.
    Valença GT; Glass PG; Negreiros NN; Duarte MB; Ventura LM; Mueller M; Oliveira-Filho J
    Parkinsonism Relat Disord; 2013 Jul; 19(7):698-700. PubMed ID: 23611687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective cohort study of impulse control disorders in Parkinson's disease.
    Bastiaens J; Dorfman BJ; Christos PJ; Nirenberg MJ
    Mov Disord; 2013 Mar; 28(3):327-33. PubMed ID: 23283708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of impulsive-compulsive behaviors in early Parkinson's disease: a prospective study.
    Marković V; Stanković I; Petrović I; Stojković T; Dragašević-Mišković N; Radovanović S; Svetel M; Stefanova E; Kostić V
    J Neurol; 2020 Apr; 267(4):1127-1136. PubMed ID: 31902006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.
    Cormier-Dequaire F; Bekadar S; Anheim M; Lebbah S; Pelissolo A; Krack P; Lacomblez L; Lhommée E; Castrioto A; Azulay JP; Defebvre L; Kreisler A; Durif F; Marques-Raquel A; Brefel-Courbon C; Grabli D; Roze E; Llorca PM; Ory-Magne F; Benatru I; Ansquer S; Maltête D; Tir M; Krystkowiak P; Tranchant C; Lagha-Boukbiza O; Lebrun-Vignes B; Mangone G; Vidailhet M; Charbonnier-Beaupel F; Rascol O; Lesage S; Brice A; Tezenas du Montcel S; Corvol JC;
    Mov Disord; 2018 Dec; 33(12):1878-1886. PubMed ID: 30444952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.